Pro Medicus Secures A$16M 7-Year Cloud Imaging Contract with TidalHealth
Pro Medicus secures a $16 million, 7-year cloud imaging contract with TidalHealth, complementing recent major wins and contract renewals that underscore its growing dominance in North American healthcare IT.
- A$16M, 7-year cloud contract with TidalHealth
- Strong contract renewals totaling A$125M in FY26
- Growing adoption of cardiology imaging modules
- Implementation pipeline driving FY27 revenue growth
- AI seen as a growth catalyst, not a threat
New Contract Strengthens Presence in Mid-Atlantic US
Pro Medicus Limited (ASX:PME) has clinched a 7-year, A$16 million contract with TidalHealth, a three-hospital system serving Delaware and the eastern shores of Maryland and Virginia. The deal, announced on 1 June 2026, covers the full Visage 7 suite; Viewer, Workflow, Open Archive; plus the increasingly popular Cardiology Imaging module, all to be implemented via the cloud with go-live targeted for Q1 2027.
This contract complements the company’s earlier wins, including a landmark A$90 million, 7-year deal with Beth Israel Lahey Health in Boston and a A$23 million, 5-year agreement with the University of Maryland Medical System. Together, these victories cement PME’s foothold across key US regions and highlight its strategy of offering a “full stack” enterprise imaging platform that now extends beyond radiology into cardiology.
Renewals Signal Client Confidence Amid Industry Shifts
CEO Dr Sam Hupert emphasised that these renewals, often with increased per-transaction fees and longer terms, challenge the narrative of a “SaaSpocalypse” triggered by AI fears. Instead, they demonstrate strong client retention and the perceived value of PME’s cloud-native platform in mission-critical healthcare environments.
AI as a Catalyst, Not a Disruptor
Addressing market concerns about AI’s impact on software companies, Dr Hupert described AI as a force multiplier for PME’s highly skilled development team rather than a threat. The company’s proprietary platform, built from the ground up over 17 years, is optimised for AI-enabled workflows, particularly in diagnostic imaging where AI can act as a “second set of eyes” to improve speed and consistency.
Rather than cutting headcount, PME is leveraging AI to boost productivity, enabling its developers to achieve what might be called “40x” output compared to traditional benchmarks. This positions PME to capitalise on AI advancements while maintaining its competitive moat in a highly regulated industry where precision is paramount.
Implementation Pipeline to Drive FY27 Revenue Growth
PME is currently executing the busiest implementation schedule in its history, with major rollouts at Trinity, BayCare in Florida, University of Heidelberg, and University of Colorado underway or imminent. While FY26 revenue will reflect some of these go-lives, the bulk of transaction volumes and associated revenue are expected to materialise in FY27, with significant contributions from University of Maryland and Beth Israel Lahey Health implementations scheduled for the second half of FY27.
This staged rollout approach aligns with client readiness and contract timing, and mirrors previous implementation cycles that resulted in notable revenue jumps in subsequent years.
Cardiology Gains Traction as Enterprise Imaging Expands
Cardiology imaging is emerging as a growth vector for PME, driven by healthcare organisations’ desire for unified enterprise imaging platforms that consolidate multiple specialty workflows. PME’s Visage 7 Cardiology module supports complex, data-intensive cardiac studies with rapid access and integration into reporting systems like Epic Cupid, streamlining clinician workflows and reducing duplication.
The recent inclusion of cardiology in contracts such as TidalHealth and MedStar Health renewals signals growing market acceptance and validates PME’s strategy to expand beyond radiology.
Bottom Line?
Pro Medicus is poised for a revenue lift in FY27 as its robust US contract pipeline and AI-enabled platform execution converge, but investors should watch implementation milestones closely.
Questions in the middle?
- How will the timing of major implementations affect PME’s FY27 revenue recognition?
- Can PME sustain its growth momentum amid intensifying competition and evolving AI technologies?
- What role will cardiology imaging play in expanding PME’s total addressable market?